UPCI / UPMC CC Press Releases
Cancer Patients and Their Families in Western Pennsylvania to Benefit from American Cancer Society Patient Navigator Program at Magee-Womens Hospital of UPMC
Pittsburgh, PA, November 8, 2010 – The American Cancer Society is launching its Patient Navigator Program at Magee-Womens Hospital of UPMC in Pittsburgh tomorrow, thanks to support received from AstraZeneca. Magee is the fourth site in Pennsylvania that is part of a nationwide effort to extend the reach of this innovative program, which assists individual cancer patients in negotiating the health care system.
"A cancer diagnosis can be a life-changing experience for patients, their families and their caregivers," said Garry Pincock, CEO, American Cancer Society East Central Division. "Our Patient Navigator Program helps patients focus on getting well by providing support every step of the way, from explaining what to expect during treatment, to making sure patients have transportation to and from appointments. Fighting cancer is a difficult, challenging journey; but with the help of trained American Cancer Society patient navigators, people don't have to go through it alone."
The American Cancer Society Patient Navigator Program directly connects a patient to a cancer education and support specialist – known as a "patient navigator" – who, through a one-on-one relationship, serves as a personal guide to patients and caregivers as they face the psychosocial, emotional and financial challenges that cancer can bring. The service is free and confidential, and places an emphasis on assisting the medically underserved.
"This generous AstraZeneca funding enables the American Cancer Society to launch a full-time Patient Navigator Program here at Magee-Womens Hospital. This enables us to assist patients with personalized community resources and support," said Judy Herstine, the administrator of the Women's Cancer Program at Magee. "This program will proactively reach those patients who are most in need of specialized services and support, and provide them with the critical link to local resources that will improve their outcomes and quality of life."
According to American Cancer Society estimates, over 74 thousand people in Pennsylvania were diagnosed with cancer in 2009. The gift is part of a $10 million pledge by AstraZeneca to the Society to accelerate development of at least 50 new Patient Navigator Program sites over a five-year period (2007 to 2011) in communities throughout the United States.
As the cancer experience is different for each patient, American Cancer Society patient navigators connect patients and caregivers with the most appropriate programs and services to help improve each individual's access to health care and to help them on their journey to get well. Whether it is getting patients and caregivers the information they need to make treatment decisions and better understand their disease, helping them deal with the day-to-day challenges of living with cancer, such as transportation and insurance issues, or connecting them with community resources such as support groups, American Cancer Society patient navigators can provide help throughout the disease continuum – from the time of diagnosis, through treatment, into survivorship. Furthermore, navigators are able to increase treatment compliance and follow-up care.
"AstraZeneca understands that, in addition to making great medicines, more can be done through meaningful collaboration with patients, health care facilities, physicians and others in the community who share our mission of improving health. We are thrilled to be the first company to give nationwide, large-scale support to the American Cancer Society Patient Navigator Program," said Lisa Schoenberg, vice-president specialty care, AstraZeneca LP. "This new program at Magee-Womens Hospital is a testament to our commitment to help provide patients with personalized cancer care, not only in Pittsburgh but in communities throughout the country."
# # #
About the American Cancer Society Patient Navigator Program
Formally launched in 2005, the Patient Navigator Program, in collaboration with community-based hospitals and cancer centers, links those affected by cancer to patient navigators who serve as personal guides for patients and their caregivers to help them navigate the cancer experience – with a focus on eliminating barriers to cancer care for the medically underserved. Patient navigators receive national-level training through the American Cancer Society, in collaboration with the National Cancer Institute Patient Navigation Research Program, as well as localized training and opportunities for ongoing education.
There are currently more than 130 American Cancer Society Patient Navigator Program sites across the U.S. The American Cancer Society Patient Navigator Program is just one of the many American Cancer Society programs that help patients, their families, and caregivers manage the impact of cancer on their lives so they can focus on getting well.
About The American Cancer Society
The American Cancer Society combines an unyielding passion with nearly a century of experience to save lives and end suffering from cancer. As a global grassroots force of more than three million volunteers, we fight for every birthday threatened by every cancer in every community. We save lives by helping people stay well by preventing cancer or detecting it early; helping people get well by being there for them during and after a cancer diagnosis; by finding cures through investment in groundbreaking discovery; and by fighting back by rallying lawmakers to pass laws to defeat cancer and by rallying communities worldwide to join the fight. As the nation's largest non-governmental investor in cancer research, contributing about $3.4 billion, we turn what we know about cancer into what we do. As a result, more than 11 million people in America who have had cancer and countless more who have avoided it will be celebrating birthdays this year. To learn more about us or to get help, call us anytime, day or night, at 1-800-227-2345 or visit cancer.org.